Condition

Coronary Artery Bypass Grafting

ClinicalTrials.gov condition label

Clinical trials5

Recruiting0

Common interventions5

Lead sponsors shown4

Clinical trials

5 shown

Oscillating Positive Expiratory Pressure (OPEP) Therapy in High Risk Patients Following Cardiac SurgeryNCT02732574 · 2016-05-01

Randomized Endo-Vein Graft ProspectiveNCT01850082 · 2013-09-30

Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPANCT00653042 · 2004-03-01

Vein-Coronary Atherosclerosis And Rosiglitazone After Bypass Surgery: The VICTORY TrialNCT00169832 · 2003-06-01

An Efficacy and Safety Study for Nesiritide in Heart Failure Patients With Reduced Kidney Function Undergoing Coronary Artery Bypass Graft Surgery Requiring Cardiopulmonary Bypass (CPB Pump or Heart Lung Machine)NCT00530361

Common interventions

NesiritideDRUG2 Oscilatory Positive Expiratory Pressure (OPEP) deviceDEVICE1 Rosiglitazone or placeboDRUG1 SHAM Device GroupDEVICE1 Vein Harvesting ProceduresPROCEDURE1

Leading sponsors

Scios, Inc.2 Laval University1 London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1 VA Office of Research and Development1

Trial status mix

COMPLETED3

UNKNOWN1

WITHDRAWN1

Phase mix

NA2

PHASE32

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.